|
Reliant Pharmaceuticals - Wikipedia, the free encyclopedia
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007. It was know for six major products, including InnoPran XL, a propranolol based beta blocker.
en.wikipedia.org/wiki/Reliant_Pharmaceuticals |
|||
|
|||
|
(NASDAQ: ALKS) today announced that it will receive up to $174 million in cash in connection with the acquisition of Reliant Pharmaceuticals, Inc. (Reliant) by GlaxoSmithKline (GSK), announced earlier today.
|
|||
|
View the Reliant Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you’re connected to Reliant Pharmaceuticals. ... Reliant Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, sales, and marketing of cardiovascular pharmaceutical products.
|
|||
|
RESEARCH TRIANGLE PARK - GlaxoSmithKline solidified its portfolio of cardiovascular therapies with its purchase of Reliant Pharmaceuticals, maker of promising heart drug Lovaza.
|
|||
|
Omacor (omega-3-acid ethyl esters; Reliant Pharmaceuticals, Inc. ... Reliant Pharmaceuticals, Inc., Liberty Corner, NJ) is a highly purified, prescription omega-3 fatty acid formulation with high concentrations of eicosapentaenoic acid (EPA) (465 mg) and docosahexaenoic acid (DHA) (375 mg) in each 1-g capsule, along with 4 mg...
|
|||
|
A former Merck exec, Brad Sheares, joined Reliant as ceo last January after the little pharma underwent a series of ups and downs, leading to speculation that a sale or an IPO was likely. We also hear, by the way, that Merck was looking at Reliant, but we have not been able to confirm that tidbit.
|
|||
|
GlaxoSmithKline has entered an agreement to acquire Reliant Pharmaceuticals Inc. for $1.65 billion in cash. Reliant is a privately held specialty pharma company focused on cardiovascular therapies. In the nine months ending September 30, 2007, the company's net sales were $341 million, up 62% YTD.
|
Copyright © 2010, Dictionary.com, LLC. All rights reserved.